Toxic shock: immune system's anthrax linkAugust 24, 2007Human immune proteins crucial for fighting cancer, viruses and bacterial infections belong to an ancient and lethal toxin family previously only found in bacteria, Australian researchers have found. These proteins, called perforins, are related to bacterial toxins that cause diseases such as anthrax, gas gangrene and scarlet fever. The discovery was made by a team led by Professor James Whisstock and Dr Michelle Dunstone from Monash University's School of Biomedical Sciences. Professor Whisstock, winner of the 2006 Science Minister's Prize for Life Scientist of the Year, said the team was stunned when it became clear that the bacterial toxins and perforins had a common ancestor. "Over millions of years of evolution bacteria developed these proteins as weapons of attack," he said. "But animals have evolved these proteins for defence against that attack. It's a molecular arms race and there's still no clear winner." Professor Whisstock said perforins were so-called because they kill bacteria, virally-infected cells and cancerous cells by punching tiny holes that perforate them. "People who lack one of these perforins can develop a serious blood disease called hemophagocytic lymphohistiocytosis and may be predisposed to develop cancer," he said. "Perforins are also dangerous molecules. They can create absolute havoc in the immune system if they're not controlled properly. By understanding how they work we can find ways to control them in infectious diseases and areas such as transplantation rejection." Using X-ray crystallography, the team worked out the structure of a perforin called Plu-MACPF, which, due to its similarity to the bacterial toxins, told them how the whole perforin family worked. Their findings are published today in the international journal Science. Dr Dunstone said the findings were the culmination of nine years of research. "Now we finally know what perforins look like and how they work, we can use this knowledge to develop new ways to fight disease," she said. Professor Whisstock said certain perforins were not only important for defending humans against attack by bacteria and viruses, but also important for propagating the human species because of their role in embryo implantation. "It is ironic that we fear diseases such as anthrax yet from the same family of toxins comes a protein that is involved in reproduction," he said. The research team included scientists from the National Health and Medical Research Council's protease systems biology program, the Australian Research Council's Centre of Excellence in Structural and Functional Microbial Genomics and the Peter MacCallum Cancer Centre. The X-ray data was collected at the Advanced Photon Source in Chicago. Monash University |
|||||||||||||||||||||
| Related Anthrax Current Events and Anthrax News Articles Milestone biodefense publication by Elsevier journal Vaccine Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense. Cigarettes Harbor Many Bacteria Harmful to Human Health Cigarettes are "widely contaminated" with bacteria, including some known to cause disease in people, concludes a new international study conducted by a University of Maryland environmental health researcher and microbial ecologists at the Ecole Centrale de Lyon in France. New explanation for nature's hardiest life form Got food poisoning? The cause might be bacterial spores, en extremely hardy survival form of bacteria, a nightmare for health care and the food industry and an enigma for scientists. Better immune defense against anthrax Scientists discover a gene in anthrax-causing bacteria may help defend against this form of bio-warfare. Argonne researchers develop method that aims to stabilize antibodies Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a systematic method to improve the stability of antibodies. Early detection and quick response are key to defense against anthrax attack A large attack on a major metropolitan area with airborne anthrax could affect more than a million people, necessitating their treatment with powerful antibiotics. Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by the New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab. One secret to how TB sticks with you Mycobacterium tuberculosis is arguably the world's most successful infectious agent because it knows how to avoid elimination by slowing its own growth to a crawl. Unexpected discovery can open a new chapter in the fight against tuberculosis A close relative of the microorganism that causes tuberculosis in humans has been found to form spores. Genetic switch potential key to new class of antibiotics Researchers have determined the structure of a key genetic mechanism at work in bacteria, including some that are deadly to humans, in an important step toward the design of a new class of antibiotics. More Anthrax Current Events and Anthrax News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||